North America Companion Animal Drugs Market To Reach US$ 14,065.8 Million By 2027 - Coherent Market Insights

1. NORTH AMERICA COMPANION ANIMAL DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION North America Companion Animal Drugs Market - Overview Companion animals are used for company, amusement, psychological support, extrovert display and all of the other functions that humans need to share with animals of other species. Statistics: North America companion animal drugs market is estimated to account for US$ 10848.0 Mn in terms of value by the end of 2020. North America Companion Animal Drugs Market: Drivers Increasing outbreak of zoonotic diseases is expected to propel growth of North America companion animal drugs market over the forecast period. For instance, according to the Center for Disease Control and Prevention, the U.S. witnessed outbreaks of Salmonella Typhimurium in pet turtles in 2020. North America Companion Animal Drugs Market: Opportunities Increasing veterinary expenditure is expected to offer lucrative growth opportunities for players in North America companion animal drugs market. For instance, according to 2017- 2018 U.S. Pet Ownership & Demographics Sourcebook of American Veterinary Medical Foundation (AVMF), the veterinary expenditure per animal in the U.S. was US$ 227 in 2012, which increased to US$ 253 in 2017-2018. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/north- america-companion-animal-drugs-market-4117 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION North America Companion Animal Drugs Market: Restraints High annual cost of owning a companion animal is expected to hinder growth of North America companion animal drugs market. For instance, according to The American Society for the Prevention of Cruelty to Animals, the annual cost of owning a dog averages as much as US$ 1,843. Key Takeaways: North America companion animal drugs market was valued at US$ 10,384.2 Mn in 2019 and is forecast to reach a value of US$ 14,065.8 Mn by 2027 at a CAGR of 3.8% between 2020 and 2027. The growth of the market is attributed to increasing prevalence of infectious diseases in companion animals along with increasing animal healthcare expenditure. Ecto-Parasiticides segment held dominant position in North America companion animal drugs market in 2019, accounting for 71.1% share in terms of value, followed by Parasiticides and Endo-Parasiticides, respectively. The growth of the segment is attributed to increasing adoption of companion animals along with new product launch during the forecasted period. Dogs, cats, pleasure horses, birds, mice, guinea pigs, and more exotic species kept by humans are considered companion animals. In 2019, the country also witnessed outbreak of Salmonella Oranienburg infections in pet turtles and campylobacter infections in pet store puppies. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4117 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Major players in North America companion animal drugs market are focused on approval and launch of new products to expand their product portfolio. For instance, in August 2018, Merial (Boehringer Ingelheim GmbH), received approval from the U.S Food and Drug Administration (FDA) to expand the label claims for NexGard (afoxolaner). NexGard can now be used to prevent Borrelia burgdorferi infections and Lyme disease in dogs. Increasing funding and support for eradication of animal diseases is expected to propel growth of North America companion animal drugs market. For instance, under the Regulation (EU) No 652/2014, the European Union offered a budget of around US$ 2 billion for 2014-2020, 65% of which is allocated to implement animal health measures. North America Companion Animal Drugs Market: Competitive Landscape Major players operating in North America companion animal drugs market include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Santé Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH. Major players in North America companion animal drugs market are also focused on adopting M&A strategies to expand their product portfolio. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4117 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved